Xiang Zhong

The microRNA miR-433 promotes renal fibrosis by amplifying the TGF-β/Smad3-Azin1 pathway.

H. Lan, Weiqin Yang, Arthur C K Chung, 2013, Kidney international.

Smad7 suppresses renal fibrosis via altering expression of TGF-β/Smad3-regulated microRNAs.

H. Lan, Rong Li, A. Chung, 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes

Xiao-ming Meng, F. Hou, H. Lan, 2013, Diabetologia.

Diverse roles of TGF‐β receptor II in renal fibrosis and inflammation in vivo and in vitro

Xiao-ming Meng, H. Lan, Haiyong Chen, 2012, The Journal of pathology.

Smad3-mediated upregulation of miR-21 promotes renal fibrosis.

Xiao-ming Meng, H. Lan, Arthur C K Chung, 2011, Journal of the American Society of Nephrology : JASN.

Stratifin promotes renal dysfunction in ischemic and nephrotoxic AKI mouse models via enhancing RIPK3-mediated necroptosis

Xiao-ming Meng, Jun Li, Yu Cai, 2021, Acta Pharmacologica Sinica.

Potential targeted therapy and diagnosis based on novel insight into growth factors, receptors, and downstream effectors in acute kidney injury and acute kidney injury-chronic kidney disease progression

Xiao-ming Meng, Jun Li, Juan Jin, 2020, Signal Transduction and Targeted Therapy.

MicroRNA-29b inhibits diabetic nephropathy in db/db mice.

Xiao-ming Meng, H. Lan, Haiyong Chen, 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

Serum levels of WNT1-inducible signaling pathway protein-1 (WISP-1): a noninvasive biomarker of renal fibrosis in subjects with chronic kidney disease.

H. Lan, Guisen Li, Li Wang, 2017, American journal of translational research.

Serum levels of WNT 1-inducible signaling pathway protein-1 ( WISP-1 ) : a noninvasive biomarker of renal fibrosis in subjects with chronic kidney disease

H. Lan, Guisen Li, Li Wang, 2017 .